Results 131 to 140 of about 692,219 (243)
Novel Therapeutics in Soft Tissue Sarcoma. [PDF]
Mavroeidis L+3 more
europepmc +1 more source
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray+2 more
wiley +1 more source
A Novel Technique of Hip Disarticulation with a Stump with Soft Tissue of the Proximal Thigh: A Case Report. [PDF]
Mizuma T+10 more
europepmc +1 more source
Deinococcus radiodurans‐derived extracellular vesicles (R1‐EVs) provide radioprotection against total‐body irradiation‐induced acute radiation syndrome in mice. R1‐EVs mitigate oxidative damage by scavenging free radicals, promoting intestinal repair, enhancing hematopoietic function, and modulating immune responses. This study highlights the potential
Jeong Moo Han+7 more
wiley +1 more source
Soft Tissue Sarcomas: An Outline Guide to Management [PDF]
Tapas K. Das Gupta
openalex +1 more source
Extra-Axial Soft Tissue Chordoma of Hand: A Rare Case Report. [PDF]
Chinnathambi PS+3 more
europepmc +1 more source
These findings advance tissue repair by offering a multifunctional filler that improves large‐scale volume retention, elasticity, and support for vascularized tissue growth. The decellularized extracellular matrix (dECM)‐based material provides low injection force and minimizes swelling, ensuring sustained volume. Combining CMC with supercritical fluid‐
Seol‐Ha Jeong+6 more
wiley +1 more source